BeStock  
Stocks › Biotechnology › ACRS

Aclaris Therapeutics ACRS

US equityMarket cap rank #3543Biotechnology
$3.44 −$0.06 (-1.71%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.44 0.00%
Open$3.44
Prev close$3.50
Day range$3.40 – $3.55
Volume2.19M
Market cap$545.63M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-6.6x
CheapRich

Around its usual level · 43rd percentile, 5-year average -5.5x

Price / book3.7x
CheapRich

Around its usual level · 60th percentile, 5-year average 3.0x

#4053 of 5329 stocks by PB (1 = cheapest)

Price / sales97.1x
CheapRich

Above its usual level · 78th percentile, 5-year average 49.5x

#4947 of 5156 stocks by PS (1 = cheapest)

P/E over five years

-15x-10x-5x1xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$6.68
Price vs. fair value-48.5%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.73 – 2.97 60% (pricier than usual) #4053 of 5329 (1 = cheapest)
PE -6.64 -5.28 -5.53 43% (cheaper than usual) –
PS 97.13 149.76 49.55 78% (pricier than usual) #4947 of 5156 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ACRS.

Sign in to join the discussion.

Scroll to Top